Table 2:
CARV infections and symptomatology
| CARV type | LRTI+URTI (n=1) | LRTI (n=18) | URTI (n=18) | Asymptomatic (n=98) |
|---|---|---|---|---|
| HRV (n=93) | 1 (1.1%) | 9 (9.7%) | 12 (12.9%) | 71 (76.3%) |
| A (n=43; 46.2%) | 1 | 7 | 6 | 29 |
| B (n=14; 15.1%) | - | 1 | 1 | 12 |
| C (n=26; 28.0%) | - | 1 | 5 | 20 |
| Unsequenced (n=10; 10.8%) | - | - | - | 10 |
| Adenovirus (n=4) | - | 1 | - | 3 |
| Human coronavirus (n=8) | - | 2 | 3 | 3 |
| Influenza (n=4) | - | 1 | - | 3 |
| hMPV (n=4) | - | 1 | - | 3 |
| PIV (n=13) | - | 3 | - | 10 |
| RSV (n=8) | - | 1 | 2 | 5 |
| Enterovirus (EDV68) (n=1) | - | - | 1 | - |
CARV = community acquired respiratory virus; URTI = upper respiratory tract infection; LRTI = lower respiratory tract infection; HRV = human rhinovirus; hMPV = human metapneumovirus; PIV = parainfluenza virus; RSV = respiratory syncytial virus